Clinical Management of Acromegaly: Therapeutic Frontiers and New Perspectives for Somatostatin Receptor Ligands (SRLs)

Somatostatin receptor ligands (SRLs) represent a true milestone in the medical therapy for acromegaly. The first-generation SRLs (FG-SRLs), octreotide and lanreotide, have demonstrated good efficacy in disease control and tumor shrinkage, and are still considered first-line medical therapies. The de...

Descripción completa

Detalles Bibliográficos
Autores principales: Brunetti, Alessandro, Antonini, Simone, Saladino, Andrea, Lavezzi, Elisabetta, Zampetti, Benedetta, Cozzi, Renato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228014/
https://www.ncbi.nlm.nih.gov/pubmed/35744057
http://dx.doi.org/10.3390/medicina58060794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228014/
https://www.ncbi.nlm.nih.gov/pubmed/35744057
http://dx.doi.org/10.3390/medicina58060794

Ejemplares similares